









Markets
/
Stocks
/
nasdaq-opk
/

OPKO Health Inc

OPK

1.120USD

-0.050-4.27%

Close 03/27, 16:00（ET）Quotes delayed by 15 min

330.47MMarket Cap

LossP/E TTM



OPKO Health Inc

1.120

-0.050-4.27%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of OPKO Health Inc

Currency: USD Updated: 2026-03-27

Key Insights

OPKO Health Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 41 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 3.40.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

OPKO Health Inc's Score

Industry at a Glance

Industry Ranking

41 / 75

Overall Ranking

205 / 4542

Industry

Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

OPKO Health Inc Highlights

StrengthsRisks

OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. The Company’s segments include pharmaceutical and diagnostics. The pharmaceutical segment consists of the pharmaceutical operations it operates in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its global pharmaceutical research and development operations. The diagnostics segment primarily consists of clinical laboratory operations through BioReference and its point-of-care operations. Its pharmaceutical business features Somatrogon (hGH-CTP), a once-weekly human growth hormone injection, and it is marketed under the brand name NGENLA. The Company, through its pharmaceutical division, manufactures and sells Rayaldee, a United States Food and Drug Administration (FDA) approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 606.88M.

Overvalued

The company’s latest PE is -3.73, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 195.81M shares, decreasing 22.08% quarter-over-quarter.

Held by PRFDX

Star Investor PRFDX holds 40.58K shares of this stock.

Analyst Rating

Based on 7 analysts

Buy

Current Rating

3.400

Target Price

+190.60%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-27

The current financial score of OPKO Health Inc is 6.97, ranking 47 out of 75 in the Healthcare Providers & Services industry. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 148.45M, representing a year-over-year decrease of 19.16%, while its net profit experienced a year-over-year decrease of 322.83%.

Score

Industry at a Glance

Previous score

6.97

Change



Financials

8.92

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.31

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

6.13

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

5.38

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.12

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

OPKO Health Inc's Company Valuation

Currency: USD Updated: 2026-03-27

The current valuation score of OPKO Health Inc is 8.03, ranking 17 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is -3.73, which is -37.74% below the recent high of -2.32 and -622.91% above the recent low of -26.95.

Score

Industry at a Glance

Previous score

8.03

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 41/75

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-27

The current earnings forecast score of OPKO Health Inc is 8.00, ranking 27 out of 75 in the Healthcare Providers & Services industry. The average price target is 3.00, with a high of 8.50 and a low of 1.60.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 7 analysts

Buy

Current Rating

3.400

Target Price

+190.60%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

OPKO Health Inc

OPK

Apple Inc

AAPL

Ge Vernova Inc

GEV

Tapestry Inc

TPR

Verisk Analytics Inc

VRSK

Avantor Inc

AVTR

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-27

The current price momentum score of OPKO Health Inc is 5.88, ranking 63 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 1.21 and the support level at 1.06, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.42

Change

-0.54

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(5)

Neutral(1)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.001

Sell

RSI(14)

40.362

Neutral

STOCH(KDJ)(9,3,3)

36.716

Sell

ATR(14)

0.045

High Vlolatility

CCI(14)

-103.547

Sell

Williams %R

83.333

Oversold

TRIX(12,20)

-0.218

Sell

StochRSI(14)

12.384

Sell

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

1.152

Sell

MA10

1.160

Sell

MA20

1.175

Sell

MA50

1.218

Sell

MA100

1.273

Sell

MA200

1.334

Sell

Institutional Confidence

Currency: USD Updated: 2026-03-27

The current institutional shareholding score of OPKO Health Inc is 3.00, ranking 59 out of 75 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 25.51%, representing a quarter-over-quarter decrease of 6.00%. The largest institutional shareholder is The Vanguard, holding a total of 32.35M shares, representing 4.26% of shares outstanding, with 14.87% increase in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Frost Gamma Investments Trust

222.46M

+0.98%

Rubric Capital Management LP

47.79M

Holbrook (Bruce C)

40.38M

Hsiao (Jane H)

33.13M

The Vanguard Group, Inc.

Star Investors

37.45M

-1.84%

BlackRock Institutional Trust Company, N.A.

29.68M

+5.19%

Frost Group, L.L.C.

30.13M

GJN 2021 Trust

19.91M

EGN 2021 Trust

19.91M

Geode Capital Management, L.L.C.

10.99M

+5.46%

Risk Assessment

Currency: USD Updated: 2026-03-27

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of OPKO Health Inc is 6.17, ranking 31 out of 75 in the Healthcare Providers & Services industry. The company's beta value is 1.49. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.